Literature DB >> 25707339

Does ovarian reserve predict egg quality in unstimulated therapeutic donor insemination cycles?

Mike Ripley1, Andrea Lanes2, Marie-Claude Léveillé3, Doron Shmorgun3.   

Abstract

OBJECTIVE: To compare reproductive outcomes of patients with very low, low, normal, and high antral follicle counts undergoing unstimulated therapeutic donor insemination (TDI) cycles.
DESIGN: Retrospective cohort study.
SETTING: University-affiliated regional fertility clinic. PATIENT(S): Four hundred fifty-nine patients who had 1,107 TDI treatment cycles from January 2006 to December 2013. INTERVENTION(S): Unstimulated therapeutic donor insemination. MAIN OUTCOME MEASURE(S): Clinical pregnancy rates and miscarriage rates as surrogate markers for oocyte quality. RESULT(S): The overall pregnancy rate per cycle start was 12.46% in the study population. There was no difference in per-cycle or cumulative pregnancy rates among patients with very low, low, average, or high antral follicle counts within each patient age group of ≤35, 36-39, and ≥40 years. The overall miscarriage rate per pregnancy was 13.61%. When stratified by patient age, there was no correlation between miscarriage rate and antral follicle count. CONCLUSION(S): AFC is not a predictor of pregnancy or miscarriage rates in patients undergoing unstimulated TDI.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diminished ovarian reserve; antral follicle count; miscarriage rate; pregnancy rate; therapeutic donor insemination

Mesh:

Year:  2015        PMID: 25707339     DOI: 10.1016/j.fertnstert.2015.01.018

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  1 in total

1.  Anti-Mullerian hormone is linked to the type of early pregnancy loss in idiopathic recurrent miscarriage: a retrospective cohort study.

Authors:  Sophie Pils; Natalia Stepien; Christine Kurz; Kazem Nouri; Regina Promberger; Johannes Ott
Journal:  Reprod Biol Endocrinol       Date:  2017-08-02       Impact factor: 5.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.